EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?

William Cayley Jr

Cochrane Clinical Answers · 2013

DOI: 10.1002/cca.100 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cochrane Clinical Answers, 2013. Verfasst von William Cayley Jr. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jr, W. C. (2013). In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.100

Vancouver

Jr WC. In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. 2013. doi:10.1002/cca.100

BibTeX
@article{Jr2013,
  author = {Jr, William Cayley},
  title = {In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?},
  journal = {Cochrane Clinical Answers},
  year = {2013},
  doi = {10.1002/cca.100}
}
Kostenlos starten →